These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4108267)

  • 1. Combined prednisolone, azathioprine, and cyclophosphamide treatment for persistent proliferative glomerulonephritis in adults.
    Mukherjee AP
    Lancet; 1971 Dec; 2(7738):1350-3. PubMed ID: 4108267
    [No Abstract]   [Full Text] [Related]  

  • 2. The glomerular tip lesion: a steroid responsive nephrotic syndrome.
    Beaman M; Howie AJ; Hardwicke J; Michael J; Adu D
    Clin Nephrol; 1987 May; 27(5):217-21. PubMed ID: 3594937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological study of nephrotic syndrome in childhood.
    White RH; Glasgow EF; Mills RJ
    Lancet; 1970 Jun; 1(7661):1353-9. PubMed ID: 4194123
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppressive therapy in adults with proliferative glomerulonephritis. Controlled trial.
    Booth LJ; Aber GM
    Lancet; 1970 Nov; 2(7681):1010-3. PubMed ID: 4098045
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome.
    White RH; Cameron JS; Trounce JR
    Br Med J; 1966 Oct; 2(5518):853-60. PubMed ID: 5917404
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytostatic treatment of nephrotic syndrome in children.
    Miltényi M; Marosvári I; Román H; Visy M; Beregi E; Szepesházi K
    Acta Paediatr Acad Sci Hung; 1970; 11(3):263-76. PubMed ID: 5525401
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe fibrin and crescent glomerulonephritis: clinical and morphological aspects of 33 patients.
    Mathew TH; Kincaid-Smith P
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):727-34. PubMed ID: 4803314
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of lupus nephritis with cyclophosphamide.
    Cameron JS; Boulton-Jones M; Robinson R; Ogg C
    Lancet; 1970 Oct; 2(7678):846-9. PubMed ID: 4097756
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypocomplementemic (membranoproliferative) glomerulonephritis. Immunosuppressive therapy.
    Holland NH; Bennett NM
    Am J Dis Child; 1972 May; 123(5):439-45. PubMed ID: 5026213
    [No Abstract]   [Full Text] [Related]  

  • 10. The nephrotic syndrome in adults with 'minimal change' glomerular lesions.
    Cameron JS; Turner DR; Ogg CS; Sharpstone P; Brown CB
    Q J Med; 1974 Jul; 43(171):461-88. PubMed ID: 4422336
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of pathogenetic therapy on blood cholesterol in patients with glomerulonephritis].
    Neverov NI; Stavrovskaia EV; Kolina IB; Shvetsov MIu; Zakharova EV; Shilov EM
    Ter Arkh; 2001; 73(6):37-40. PubMed ID: 11521519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are anticoagulants beneficial in the treatment of rapidly progressive glomerulonephritis?
    Cameron JS
    Proc Eur Dial Transplant Assoc; 1973; 10(0):57-90. PubMed ID: 4606240
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of the nephrotic syndrome.
    Linshaw MA; Gruskin AB
    Clin Pediatr (Phila); 1974 Jan; 13(1):45-51. PubMed ID: 4588668
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunosuppressive treatment of glomerulonephritis and nephrotic syndrome].
    Stojimirović B
    Med Glas; 1971; 25(7):273-6. PubMed ID: 5148090
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxic agents in childhood glomerulonephritis.
    Barratt M
    Arch Dis Child; 1972 Apr; 47(252):159-62. PubMed ID: 4554082
    [No Abstract]   [Full Text] [Related]  

  • 16. Azathioprine in glomerulonephritis. A long-term study.
    McIntosh RM; Griswold W; Smith FG; Kaufman DB; Urizar R; Vernier RL
    Lancet; 1972 May; 1(7760):1085-9. PubMed ID: 4112570
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytotoxic drugs in steroid-resistant renal disease. Alkylating and antimetabolic agents in the treatment of nephrotic syndrome, lupus nephritis, chronic glomerulonephritis, and purpura nephritis in children.
    Grupe WE; Heymann W
    Am J Dis Child; 1966 Nov; 112(5):448-58. PubMed ID: 5917978
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic studies in NZB-W mice. II. Relative efficacy of azathioprine, cyclophosphamide and methylprednisolone.
    Gelfand MC; Steinberg AD
    Arthritis Rheum; 1972; 15(3):247-52. PubMed ID: 5031609
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis.
    Brown CB; Wilson D; Turner D; Cameron JS; Ogg CS; Chantler C; Gill D
    Lancet; 1974 Nov; 2(7890):1166-72. PubMed ID: 4139590
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunosuppressive therapy of proliferative glomerulonephritis in children.
    Urizar RE; Tinglof B; McIntosh R; Litman N; Barnett E; Wilkerson J; Smith F; Vernier RL
    Am J Dis Child; 1969 Sep; 118(3):411-25. PubMed ID: 4896973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.